These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2475843)

  • 1. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
    Bandyopadhyay SK; D'Andrea E; Fleissner E
    Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
    Suchy BK; Sarafoff M; Kerler R; Rabes HM
    Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
    Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C
    Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of c-myc expression in a human hepatoma cell line.
    Huber BE; Thorgeirsson SS
    Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of c-myc gene regulation in folic acid-induced kidney regeneration.
    Asselin C; Marcu KB
    Oncogene Res; 1989; 5(1):67-72. PubMed ID: 2476708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of c-myc transcription involves myc family proteins.
    Cleveland JL; Huleihel M; Bressler P; Siebenlist U; Akiyama L; Eisenman RN; Rapp UR
    Oncogene Res; 1988; 3(4):357-75. PubMed ID: 2976141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM; Rabbitts PH
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
    Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
    Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R; Babinet C; Cremisi C
    Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
    Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D; Polack A; Kofler E; Bornkamm GW
    Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
    Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
    Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.